Cargando…
Transcriptome sequencing revealed differences in the response of renal cancer cells to hypoxia and CoCl (2) treatment
Human cancer cells are subjected to hypoxic conditions in many tumours. Hypoxia causes alterations in the glycolytic pathway activation through stabilization of hypoxia-inducible factor 1. Currently, two approaches are commonly used to model hypoxia: an alternative to generating low-oxygen condition...
Autores principales: | Zhigalova, Nadezhda, Artemov, Artem, Mazur, Alexander, Prokhortchouk, Egor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712771/ https://www.ncbi.nlm.nih.gov/pubmed/26925226 http://dx.doi.org/10.12688/f1000research.7571.1 |
Ejemplares similares
-
VHL inactivation without hypoxia is sufficient to achieve genome hypermethylation
por: Artemov, Artem V., et al.
Publicado: (2018) -
Assessing the protective effects of cryptotanshinone on CoCl(2)-induced hypoxia in RPE cells
por: Gu, Yu, et al.
Publicado: (2021) -
The hypoxia-mimetic agent CoCl(2) induces chemotherapy resistance in LOVO colorectal cancer cells
por: YANG, GUANGLEI, et al.
Publicado: (2016) -
Identification of Key Players Involved in CoCl(2) Hypoxia Induced Pulmonary Artery Hypertension in vitro
por: Chen, Shu, et al.
Publicado: (2020) -
Promoting cardioprotection with fenugreek: Insights from CoCl(2)-induced hypoxia in neonatal rat cardiomyocytes
por: Hanafi, Noorul Izzati, et al.
Publicado: (2023)